News

Scientific news
<p>Aleix Prat (IDIBAPS), Roger Gomis (IRB Barcelona) and Juan Miguel Cejalvo (PhD student in the joint programme PhD4MD)</p>
20 Apr 2017

Researchers at IDIBAPS and IRB Barcelona have described in Cancer Research, that the longer the time from the onset of the tumour to the development of metastasis is, the more aggressive this cancer becomes.

Institutional news
<p>The 8th “Vi per Vida” (Wine for Life) will be held on Sunday 7 May in Mollerussa.</p>
12 Apr 2017

The 8th “Vi per Vida” (“Wine for Life” in English) will be held for 300 participants on Sunday 7 May in Mollerussa and will cost 10 euros per person.

The event aims to raise funds to support research into cancer and metastasis conducted at IRB Barcelona.

This fundraising initiative draws public attention to the importance of scientific research.

Institutional news
<p>Fran Supek is starting his Genome Data Science (aGENDAS) laboratory at IRB Barcelona.</p>
10 Apr 2017

Croatian scientist Fran Supek is launching his Genome Data Science (aGENDAS) laboratory.

aGENDAS is starting this April and will promote the research in Big Data, an strategic area also for the Barcelona Institute of Science and Technology (BIST).

With this new group, the Institute now hosts 24 laboratories and seven core facilities.

Institutional news
<p>The BIST founding conference took place on 31st March at the CCCB in Barcelona. (Image: BIST)</p>
4 Apr 2017

The announcement took place during the BIST Founding Conference on Friday 31 March at the Centre de Cultura Contemporània de Barcelona.

Institutional news
<p>The fruit fly (Drosophila melanogaster), a means to model and study human disease.</p>
23 Mar 2017

100 secondary school students aged between 16 and 18 years old will have the chance to experience the Barcelona International Youth Science Challenge (BIYSC) 2017.

It is a two-week (10-21 July) scientific summer camp organised by the Catalunya-La Pedrera Foundation in collaboration with first-class research centres all over Catalonia.

The registration period is now open for BIYSC, in which IRB Barcelona coordinates a project in biomedicine.

Institutional news
<p>IRB Barcelona's Innovation team strengthens ties with industry.</p>
20 Mar 2017

The 11th international partnering conference comes to Barcelona from 20 to 22 March.

19 young researchers at IRB Barcelona will also be attending the three-day conference.

BIO-Europe Spring is the premier springtime partnering conference for the biotechnology industry.

Institutional news
<p>Teachers and scientists working together.</p>
17 Mar 2017

IRB Barcelona is to participate in the twelfth edition of the Catalunya La Pedrera Foundation's Teachers and Science Programme.

Teachers will work alongside the scientists to develop resources that can be taken back to the classroom.

Institutional news
<p>IRB Barcelona celebrates 10 years of ERC.</p>
17 Mar 2017

IRB Barcelona has received 18 M € funding for 11 projects in the fields of Life Sciences and of Physics and Engineering.

Scientific news
<p>Left, atomic structure of RNA polymerase I in its inactive form - homodimer; Right, atomic structure of RNA polymerase I in its active form -heterodimer with Rrn3-. (Carlos Fernández-Tornero CIB/CSIC and Oriol Gallego, IRB Barcelona)</p>
16 Mar 2017

Researchers unveil a mechanism responsible for halting protein synthesis when cells are deprived of nutrients.

The cell regulates its growth by forming various assemblies of RNA polymerase I.

The study has implications for cancer research.

Scientific news
<p>The image shows tumour cells infected by the virus, which expresses a fluorescent protein. Over the days (in the image fifth day), the virus multiplies, generating new virions that infect more cancer cells (IDIBAPS, IRB Barcelona)</p>
16 Mar 2017

IDIBAPS and IRB Barcelona researchers show the effectiveness of a new strategy to achieved genetically modified viruses that infect only tumor cells, thus preserving healthy tissues.

It is an innovative approach that exploits the different expression profiles of certain proteins between tumor and healthy cells, thus allowing the virus to infect only the former.